Ostomy drainage bags market to reach $2.88 billion by 2030

The ostomy drainage bags market is projected to grow from $2.24 billion in 2025 to $2.36 billion in 2026, with North America leading in 2025 and Asia-Pacific expected to grow fastest. The market’s expansion is tied to rising cancer cases, more ostomy surgeries, home healthcare growth and demand for longer-term urinary management.

Why it matters: - Ostomy drainage bags are tied to long-term urinary management for patients with bladder function problems. - Market growth signals rising demand for post-operative care products, home healthcare support and more comfortable medical devices. - The market is projected to reach $2.88 billion by 2030, underscoring steady demand in a category shaped by cancer care and aging populations.

What happened: - The Business Research Company projected the global ostomy drainage bags market will rise from $2.24 billion in 2025 to $2.36 billion in 2026. - The forecast implies a 5.2% compound annual growth rate in 2026. - The market is expected to continue growing through 2030 at a 5.1% CAGR. - A free sample of the report is available here. - The full report is available here.

The details: - The market’s recent growth has been driven by higher rates of colorectal and bladder cancers. - More ostomy surgeries have also supported demand. - Better access to post-operative care products has helped expand the market. - Home healthcare services have broadened the use case for ostomy drainage bags. - Advanced ostomy materials have added to product adoption. - An ostomy urinary drainage bag is a medical device connected to a catheter that collects and drains urine. - The bags are used when bladder function is impaired or urine flow is disrupted. - The bags are typically coated with liquid-impermeable materials to contain urine safely and reduce leakage. - Rising bladder cancer cases are expected to increase demand for drainage bags. - Cancer Research UK projected in September 2025 that the European age-standardized incidence rate of bladder cancer among women in the UK will fall about 11% between 2024–2026 and 2038–2040, from about 7.2 to 6.5 cases per 100,000 annually. - Cancer Research UK projected the rate among men in the UK will drop about 14% over the same period, from about 21.7 to 18.7 cases per 100,000 annually. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

Between the lines: - Even with some expected declines in UK bladder cancer incidence, the market still benefits from broader prevalence and ongoing urinary-care needs. - The forecast points to a shift toward products designed for comfort, discretion and infection prevention. - Demand for leak-resistant systems and skin-friendly materials appears to be becoming a competitive requirement. - North America held the largest market share in 2025, but Asia-Pacific is expected to be the fastest-growing region over the forecast period. - The report’s new additions, including TAM analysis, company scoring matrices and forecasting dashboards, suggest the market is being positioned as a more data-driven category for suppliers and investors.

What's next: - Market growth is expected to be supported by aging populations with urological conditions. - Home-based patient care is likely to remain an important demand driver. - Product innovation will likely focus on multi-functional designs, better comfort and stronger infection-prevention features. - Asia-Pacific’s growth trajectory could reshape regional competition as manufacturers target expanding healthcare markets.